033eur
-5,5 %
Date:2024-07-24Time:17:29:00Latest report:Q4-2023List:First NorthTicker:BONEH
Market Cap:7 meurEnterprise Value:10 meurNet Sales:- meurEarnings:-3,48 meurEmployees:0ISIN:FI4000260583

Ratios

10-year key figure history for BBS-Bioactive Bone turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for BBS-Bioactive Bone with index and moving average MA50 and MA200.

Stockprice:0,33
MA50:0,36
MA200:0,45
Price/MA200:-28,1 %
RSI (14):45,5
Price/MA50:-10,4 %

Description

BBS-Bioactive Bone Substitutes PLC) is a biomedical technology company that develops, manufactures, and commercializes innovative, bioactive medical devices and implants for orthopaedic surgery, and develops, designs, and manufactures bioactive bone-graft substitute implants. Its ortho-biological product ARTEBONE, which is based on tricalcium phosphate and a natural spectrum of bone proteins has the capability of bone regeneration.

Medical Equipment